Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Rhodes Melissa, holds the title of Chief Operating Officer at Avalyn Pharma Inc..
On 2026-11-17, the insider transacted 26,600 shares.The shares were transacted at a weighted average price of $16.26 per share, resulting in a total market-relevant value of $432K.
Rhodes Melissa (Chief Operating Officer) sold $432K of $AVLN
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.